116 related articles for article (PubMed ID: 2480377)
41. Expression of mucin (MUC-1) from a mini-Epstein-Barr virus in immortalized B-cells to generate tumor antigen specific cytotoxic T cells.
Kilger E; Pecher G; Schwenk A; Hammerschmidt W
J Gene Med; 1999; 1(2):84-92. PubMed ID: 10738572
[TBL] [Abstract][Full Text] [Related]
42. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
Semple JW; Ellis J; Delovitch TL
J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
[TBL] [Abstract][Full Text] [Related]
43. Specific Schistosoma mansoni rat T cell clones. I. Generation and functional analysis in vitro and in vivo.
Pestel J; Dissous C; Dessaint JP; Louis J; Engers H; Capron A
J Immunol; 1985 Jun; 134(6):4132-9. PubMed ID: 2580907
[TBL] [Abstract][Full Text] [Related]
44. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
45. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.
Puri J; Factorovich Y
J Immunol; 1988 Nov; 141(10):3313-7. PubMed ID: 3263420
[TBL] [Abstract][Full Text] [Related]
46. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis.
Shimoda S; Nakamura M; Shigematsu H; Tanimoto H; Gushima T; Gershwin ME; Ishibashi H
Hepatology; 2000 Jun; 31(6):1212-6. PubMed ID: 10827144
[TBL] [Abstract][Full Text] [Related]
47. OH. treatment of tetanus toxin reduces its susceptibility to limited proteolysis with more efficient presentation to specific T cells.
Pernollet M; Villiers C; Gabert F; Drouet C; Colomb M
Mol Immunol; 1993 Dec; 30(18):1639-46. PubMed ID: 8272077
[TBL] [Abstract][Full Text] [Related]
48. Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity.
Barbey C; Watts C; Corradin G
Eur J Immunol; 1995 Jan; 25(1):30-6. PubMed ID: 7843248
[TBL] [Abstract][Full Text] [Related]
49. Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints, degenerate binding, and promiscuous recognition.
Panina-Bordignon P; Demotz S; Corradin G; Lanzavecchia A
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():445-51. PubMed ID: 2484166
[No Abstract] [Full Text] [Related]
50. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
51. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
Roosnek E; Lanzavecchia A
J Exp Med; 1991 Feb; 173(2):487-9. PubMed ID: 1703209
[TBL] [Abstract][Full Text] [Related]
52. Scanning for T helper epitopes with human PBMC using pools of short synthetic peptides.
Reece JC; McGregor DL; Geysen HM; Rodda SJ
J Immunol Methods; 1994 Jun; 172(2):241-54. PubMed ID: 7518486
[TBL] [Abstract][Full Text] [Related]
53. Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive.
O'Hern PA; Liang ZG; Bambra CS; Goldberg E
Vaccine; 1997 Nov; 15(16):1761-6. PubMed ID: 9364680
[TBL] [Abstract][Full Text] [Related]
54. Antigen presentation by non-immune B-cell hybridoma clones: presentation of synthetic antigenic sites reveals clones that exhibit no specificity and clones that present only one epitope.
Cohly HH; Morrison DR; Atassi MZ
Immunol Invest; 1989 Oct; 18(8):987-92. PubMed ID: 2479600
[TBL] [Abstract][Full Text] [Related]
55. Involvement of the Zn-binding region of tetanus toxin in B and T recognition. Influence of Zn fixation.
Villiers MB; Gabert FM; Jacquier MR; Villiers CL; Colomb MG
Mol Immunol; 1993 Feb; 30(2):129-36. PubMed ID: 7679184
[TBL] [Abstract][Full Text] [Related]
56. A novel and simple procedure for determining T cell epitopes in protein antigens.
Demotz S; Matricardi P; Lanzavecchia A; Corradin G
J Immunol Methods; 1989 Aug; 122(1):67-72. PubMed ID: 2474615
[TBL] [Abstract][Full Text] [Related]
57. C3b covalently associated to tetanus toxin modulates TT processing and presentation by U937 cells.
Rey-Millet CA; Villiers CL; Gabert FM; Chesne S; Colomb MG
Mol Immunol; 1994 Dec; 31(17):1321-7. PubMed ID: 7997244
[TBL] [Abstract][Full Text] [Related]
58. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen.
Watts C; Antoniou A; Manoury B; Hewitt EW; Mckay LM; Grayson L; Fairweather NF; Emsley P; Isaacs N; Simitsek PD
Immunol Rev; 1998 Aug; 164():11-6. PubMed ID: 9795759
[TBL] [Abstract][Full Text] [Related]
59. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.
Grillot D; Valmori D; Lambert PH; Corradin G; Del Giudice G
Infect Immun; 1993 Jul; 61(7):3064-7. PubMed ID: 7685741
[TBL] [Abstract][Full Text] [Related]
60. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants.
Simitsek PD; Campbell DG; Lanzavecchia A; Fairweather N; Watts C
J Exp Med; 1995 Jun; 181(6):1957-63. PubMed ID: 7539034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
